<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(5)</volume><submitter>Vahlas Z</submitter><pubmed_abstract>Tuberculosis (TB) is a significant aggravating factor in individuals living with HIV-1, the causative agent for AIDS. Both &lt;i>Mycobacterium tuberculosis&lt;/i> (Mtb), the bacterium responsible for TB, and HIV-1 target macrophages. Understanding how Mtb subverts these cells may facilitate the identification of new druggable targets. Here, we explored how TB can induce macrophages to form tunneling nanotubes (TNT), promoting HIV-1 spread. We found that TB triggers metabolic rewiring of macrophages, increasing their glycolytic ATP production. Using several pharmacological inhibitors, glucose deprivation, and glucose or galactose supplementation, we discovered that disrupting aerobic glycolysis significantly reduces HIV-1 infection in these macrophages. Glycolysis is essential for tunneling nanot</pubmed_abstract><journal>Life science alliance</journal><pagination>e202503333</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12920055</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages.</pubmed_title><pmcid>PMC12920055</pmcid><pubmed_authors>Barros J</pubmed_authors><pubmed_authors>Corti M</pubmed_authors><pubmed_authors>Vahlas Z</pubmed_authors><pubmed_authors>Faivre N</pubmed_authors><pubmed_authors>Ben Neji M</pubmed_authors><pubmed_authors>Maio M</pubmed_authors><pubmed_authors>Lucas A</pubmed_authors><pubmed_authors>Letisse F</pubmed_authors><pubmed_authors>Verollet C</pubmed_authors><pubmed_authors>Raynaud-Messina B</pubmed_authors><pubmed_authors>Vu Manh TP</pubmed_authors><pubmed_authors>Hertel Q</pubmed_authors><pubmed_authors>Monard SC</pubmed_authors><pubmed_authors>Blanchet F</pubmed_authors><pubmed_authors>Pingret M</pubmed_authors><pubmed_authors>Deyts C</pubmed_authors><pubmed_authors>Neyrolles O</pubmed_authors><pubmed_authors>Fried S</pubmed_authors><pubmed_authors>Poincloux R</pubmed_authors><pubmed_authors>Lugo-Villarino G</pubmed_authors><pubmed_authors>Balboa L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages.</name><description>Tuberculosis (TB) is a significant aggravating factor in individuals living with HIV-1, the causative agent for AIDS. Both &lt;i>Mycobacterium tuberculosis&lt;/i> (Mtb), the bacterium responsible for TB, and HIV-1 target macrophages. Understanding how Mtb subverts these cells may facilitate the identification of new druggable targets. Here, we explored how TB can induce macrophages to form tunneling nanotubes (TNT), promoting HIV-1 spread. We found that TB triggers metabolic rewiring of macrophages, increasing their glycolytic ATP production. Using several pharmacological inhibitors, glucose deprivation, and glucose or galactose supplementation, we discovered that disrupting aerobic glycolysis significantly reduces HIV-1 infection in these macrophages. Glycolysis is essential for tunneling nanot</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 May</publication><modification>2026-07-16T13:00:19.387Z</modification><creation>2026-07-09T10:56:17.152Z</creation></dates><accession>S-EPMC12920055</accession><cross_references><pubmed>41714137</pubmed><doi>10.26508/lsa.202503333</doi></cross_references></HashMap>